logo-icon-img
Ctrl+K

RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)

Inactive on SAM.gov — responses were due 30 Jul 2026 · No Set aside used · Office of Assistant Secretary for Preparedness and Response, HHS · Washington, DC · NAICS 541714 · Solicitation 75A50126R00002

Following NAICS 541714? Get new solicitations in it by email as they post — no account needed.

Email me new ones

A newer version of this notice has been posted. SAM.gov republished solicitation 75A50126R00002 on 08 July 2026. This page is kept because it is a real record, but the current requirement, dates and attachments are on the latest version. Read the latest version →

What happened next

SAM.gov marked this notice inactive — responses were due 30 July 2026.

No award notice on SAM.gov yet. Not every award is posted there, so this does not mean it went unawarded.

Email me when the award is announced. One email, when SAM.gov posts the award notice. Not every award is posted there; if none appears within six months we'll tell you and stop. No account needed.

Solicitation details

Solicitation number75A50126R00002
Notice IDbe03780f242f416dbd6cd977dc2fda80
AgencyDepartment of Health and Human Services (HHS)
Sub-agencyOffice of Assistant Secretary for Preparedness and Response
Contracting officeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS code541714 — Research and Development in Biotechnology (Except Nanobiotechnology)
Product / service code (PSC)AB12
Set-asideNo Set aside used
Notice typeSolicitation
Posted02 July 2026
Response deadline30 July 2026 (closed)
Place of performanceWashington, DC, USA

Get new NAICS 541714 solicitations by email

This one has closed. We'll email you when new NAICS 541714 (Research and Development in Biotechnology (Except Nanobiotechnology)) solicitations post — the first email lists what is open right now, then at most once a week, only when something new posts. No account needed; unsubscribe in a click.

Description

BARDA seeks late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.

Version history

SAM.gov has posted 6 notices under solicitation 75A50126R00002, oldest first.

Go deeper on this solicitation

FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.

Open the AI analysis in FedSift →

Free forever plan — no credit card. Browse solicitations without an account; sign in for AI analysis and matching.

Market context: HHS and NAICS 541714

About the buyer and the industry, not this specific solicitation. Source: USASpending.gov award data, updated nightly.

  • In fiscal year 2026, HHS obligated $706.8M across 154 contract actions under NAICS 541714.
  • 224 contracts worth $1.6B in this category end within the next 18 months.

HHS contracts under NAICS 541714 →

Other open solicitations in NAICS 541714

All NAICS 541714 solicitations →

More from Department of Health and Human Services

All HHS solicitations →

Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.

FedSift turns SAM.gov and USASpending data into federal BD intelligence — smart matches, recompete radar, cited AI solicitation analysis and compliance matrices.

Source data: SAM.gov (solicitations) and USASpending.gov (awards), refreshed nightly. FedSift is not affiliated with the U.S. Government.

Pricing · Privacy · Terms · support@fedsift.app

FedSift dashboard